MyFinsight
Home
Blog
About
Marketable securities
$144,426K
(84.94%↑ Y/Y)
Cash and cash
equivalents
$35,453K
(55.11%↑ Y/Y)
Prepaid expenses and
other current assets
$1,011K
(-80.73%↓ Y/Y)
Total property and
equipmentat cost
$6,913K
(2.69%↑ Y/Y)
Total current assets
$180,890K
(70.34%↑ Y/Y)
Operating lease,
right-of-use ('rou') asset
$8,391K
(-14.41%↓ Y/Y)
Restricted cash
$568K
(0.00%↑ Y/Y)
Property and equipment,
net
$324K
(147.33%↑ Y/Y)
Less accumulated
depreciation
$6,589K
(-0.18%↓ Y/Y)
Total assets
$190,173K
(62.96%↑ Y/Y)
Total liabilities and
stockholders' equity
$190,173K
(62.96%↑ Y/Y)
Total stockholders'
equity
$166,049K
(78.15%↑ Y/Y)
Total liabilities
$24,124K
(2.69%↑ Y/Y)
Accumulated deficit
-$474,643K
(-18.31%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$251K
(-220.67%↓ Y/Y)
Additional
paid-in-capital
$640,925K
(29.69%↑ Y/Y)
Total current
liabilities
$16,128K
(16.38%↑ Y/Y)
Operating lease
obligations, long-term...
$7,996K
(-16.99%↓ Y/Y)
Common stock, 0.0001
par value 300,000...
$18K
(28.57%↑ Y/Y)
Accrued expenses
$11,585K
(5.39%↑ Y/Y)
Accounts payable
$2,906K
(11.98%↑ Y/Y)
Operating lease
obligations, current portion
$1,637K
(504.06%↑ Y/Y)
Back
Back
Balance Sheet
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)
source: myfinsight.com